Connecticut 2021 Regular Session

Connecticut Senate Bill SB01051 Compare Versions

Version 1 (Old)

Version 2 (New)

Old	New		Differences
1	1
2	2
3		-	LCO \\PRDFS1\SCOUSERS\FORZANOF\WS\2021SB-01051-R01-
4		-	SB.docx
5		-	1 of 5
	3	+	LCO No. 4520 1 of 5
6	4
7		-	General Assembly ~~Substitute~~ Bill No. 1051
	5	+	General Assembly Raised Bill No. 1051
8	6		January Session, 2021
	7	+	LCO No. 4520
	8	+
	9	+
	10	+	Referred to Committee on INSURANCE AND REAL ESTATE
	11	+
	12	+
	13	+	Introduced by:
	14	+	(INS)
	15	+
9	16
10	17
11	18
12	19		AN ACT ESTABLISHING A TASK FORCE TO STUD Y MEDICAL
13	20		PRACTICE OWNERSHIP M ODELS.
14	21		Be it enacted by the Senate and House of Representatives in General
15	22		Assembly convened:
16	23
17	24		Section 1. (Effective from passage) (a) There is established a task force 1
18	25		to study the corporate practice of medicine doctrine, health carrier 2
19	26		ownership of medical practices located in this state and medical practice 3
20	27		ownership models that ensure the integrity of medical judgments, 4
21	28		optimize patient outcomes and minimize corporate influence and 5
22	29		interests. Such study shall include, but need not be limited to: 6
23	30		(1) An examination of: 7
24	31		(A) The extent to which health carriers have acquired, and are 8
25	32		acquiring, medical practices in this state; 9
26	33		(B) The medical practice ownership models emerging in this state; 10
27	34		(C) The effects that health carrier ownership of medical practices has 11
28	35		in this state, including, but not limited to, any effect on: 12
29		-	(i) Patient health outcomes; 13
30		-	(ii) Health care costs; 14
31		-	(iii) Provider network size; 15 Substitute Bill No. 1051
	36	+	(i) Patient health outcomes; 13 Raised Bill No. 1051
32	37
33	38
34		-	LCO {\\PRDFS1\SCOUSERS\FORZANOF\WS\2021SB-01051-
35		-	R01-SB.docx }
36		-	2 of 5
37	39
	40	+	LCO No. 4520 2 of 5
	41	+
	42	+	(ii) Health care costs; 14
	43	+	(iii) Provider network size; 15
38	44		(iv) Timely access to health care; 16
39	45		(v) Health care quality; 17
40	46		(vi) Patient outcome monitoring; 18
41	47		(vii) Health care providers; 19
42	48		(viii) Potential conflicts of interest in health care decision-making; 20
43	49		(ix) Administrative processes, efficiency and the benefits and costs 21
44		-	associated with such effect; or 22
	50	+	associated with such effect; 22
45	51		(x) Health care provider reporting requirements; and 23
46	52		(D) The effects that health carrier ownership of medical practices has 24
47	53		in this state in comparison to the effects that other medical practice 25
48	54		ownership models have in this state, including, but not limited to, a 26
49	55		comparison of effects on: 27
50	56		(i) Patient health outcomes; 28
51	57		(ii) Costs; 29
52	58		(iii) Pricing; 30
53	59		(iv) Efficiency; and 31
54	60		(v) Quality of care; 32
55	61		(2) A benchmarking exercise to compare the effects of health carrier 33
56		-	ownership of medical practices to the effects of other medical practice 34
57		-	ownership models in this state, other states and across states for the 35
58		-	purpose of gathering as much data and information as possible to make 36
59		-	an evidence-based comparison; and 37
	62	+	ownership of medical practices in comparison to the effects of other 34
	63	+	medical practice ownership models in this state, other states and across 35
	64	+	states for the purpose of gathering as much data and information as 36
	65	+	possible to make an evidence-based comparison; and 37 Raised Bill No. 1051
	66	+
	67	+
	68	+
	69	+	LCO No. 4520 3 of 5
	70	+
60	71		(3) Methods available to address the adverse impacts of certain 38
61	72		medical practice ownership models, including, but not limited to, 39
62		-	codifying the corporate practice of medicine doctrine in this state. 40 Substitute Bill No. 1051
63		-
64		-
65		-	LCO {\\PRDFS1\SCOUSERS\FORZANOF\WS\2021SB-01051-
66		-	R01-SB.docx }
67		-	3 of 5
68		-
	73	+	codifying the corporate practice of medicine doctrine in this state. 40
69	74		(b) Except as provided in subsection (d) of this section, the task force 41
70	75		shall consist of the following members: 42
71	76		(1) Two appointed by the speaker of the House of Representatives, 43
72	77		one of whom is a physician practicing in a privately-owned medical 44
73	78		practice and one of whom is a physician practicing in a health carrier-45
74	79		owned medical practice; 46
75	80		(2) Two appointed by the president pro tempore of the Senate, one of 47
76	81		whom is a physician practicing in a federally qualified health center and 48
77	82		one of whom is a physician practicing in a hospital-owned or affiliated 49
78	83		medical practice; 50
79	84		(3) Two appointed by the majority leader of the House of 51
80	85		Representatives, one of whom has expertise in health economics, 52
81	86		insurance or pricing and one of whom has expertise analyzing health 53
82	87		care provider metrics for a health carrier; 54
83	88		(4) Two appointed by the majority leader of the Senate, one of whom 55
84	89		has expertise in public health policy and one of whom has expertise 56
85	90		analyzing health care provider metrics for a health care provider; 57
86	91		(5) Two appointed by the minority leader of the House of 58
87	92		Representatives, one of whom has a background in patient advocacy 59
88	93		and one of whom is an attorney who has experience practicing antitrust 60
89	94		law; 61
90	95		(6) Two appointed by the minority leader of the Senate, one of whom 62
91	96		has a background in health equity advocacy and one of whom has 63
92	97		expertise in medical ethics; 64
93	98		(7) The Comptroller, or the Comptroller's designee; 65
94		-	(8) The Insurance Commissioner, or the commissioner's designee; 66
95		-	(9) The Healthcare Advocate, or the Healthcare Advocate's designee; 67
96		-	and 68 Substitute Bill No. 1051
	99	+	(8) The Insurance Commissioner, or the commissioner's designee; 66 Raised Bill No. 1051
97	100
98	101
99		-	LCO {\\PRDFS1\SCOUSERS\FORZANOF\WS\2021SB-01051-
100		-	R01-SB.docx }
101		-	4 of 5
102	102
	103	+	LCO No. 4520 4 of 5
	104	+
	105	+	(9) The Healthcare Advocate, or the Healthcare Advocate's designee; 67
	106	+	and 68
103	107		(10) The executive director of the Office of Health Strategy, or the 69
104	108		executive director's designee. 70
105	109		(c) Any member of the task force appointed under subdivision (1), 71
106	110		(2), (3), (4), (5) or (6) of subsection (b) of this section may be a member 72
107	111		of the General Assembly. 73
108	112		(d) All initial appointments to the task force shall be made not later 74
109	113		than thirty days after the effective date of this section. If an appointing 75
110	114		authority fails to make an initial appointment under subdivision (1), (2), 76
111	115		(3), (4), (5) or (6) of subsection (b) of this section before the expiration of 77
112	116		such period, the chairs of the joint standing committee of the General 78
113	117		Assembly having cognizance of matters relating to insurance shall 79
114	118		jointly make such initial appointment and the member appointed by the 80
115	119		chairs shall serve until the appointing authority appoints a member to 81
116	120		replace the member initially appointed by the chairs. Any member 82
117	121		appointed by the chairs pursuant to this subsection may be a member of 83
118	122		the General Assembly. Except as otherwise provided in this subsection, 84
119	123		any vacancy shall be filled by the appointing authority. 85
120	124		(e) The speaker of the House of Representatives and the president pro 86
121	125		tempore of the Senate shall select the chairpersons of the task force from 87
122	126		among the members of the task force. Such chairpersons shall schedule 88
123	127		the first meeting of the task force, which shall be held not later than sixty 89
124	128		days after the effective date of this section. 90
125	129		(f) The administrative staff of the joint standing committee of the 91
126	130		General Assembly having cognizance of matters relating to insurance 92
127	131		shall serve as administrative staff of the task force. 93
128	132		(g) Not later than January 1, 2022, the task force shall submit a report 94
129	133		on its findings and recommendations to the joint standing committees 95
130	134		of the General Assembly having cognizance of matters relating to 96
131		-	human services, insurance and public health in accordance with the 97
132		-	provisions of section 11-4a of the general statutes. The task force shall 98
133		-	terminate on the date that it submits such report or January 1, 2022, 99 Substitute Bill No. 1051
	135	+	human services, insurance and public health in accordance with the 97 Raised Bill No. 1051
134	136
135	137
136		-	LCO {\\PRDFS1\SCOUSERS\FORZANOF\WS\2021SB-01051-
137		-	R01-SB.docx }
138		-	5 of 5
139	138
	139	+	LCO No. 4520 5 of 5
	140	+
	141	+	provisions of section 11-4a of the general statutes. The task force shall 98
	142	+	terminate on the date that it submits such report or January 1, 2022, 99
140	143		whichever is later. 100
141	144		This act shall take effect as follows and shall amend the following
142	145		sections:
143	146
144	147		Section 1 from passage New section
145	148
146		-	Statement of ~~Legislative Commissioners~~:
147		-	~~In Subsec~~. ~~(a)(1)(C)(ix), "or" was added for consistency, and in Subsec.~~
148		-	~~(a)(2)~~, ~~"in comparison" was deleted for clarity.~~
149		-
150		-	~~INS Joint Favorable Subst. -LCO~~
	149	+	Statement of Purpose:
	150	+	To establish a task force to study medical practice ownership models.
	151	+	[Proposed deletions are enclosed in brackets. Proposed additions are indicated by underline, except
	152	+	that when the entire text of a bill or resolution or a section of a bill or resolution is new, it is not
	153	+	underlined.]
151	154